Bivalirudin for treatment of LVAD thrombosis: A case series

ASAIO Journal

Volumn 60, Issue 6, 2014, Pages 744-747

  Sylvia, Lynne M ^a,b   Ordway, Linda ^a   Pham, Duc T ^a,c   DeNofrio, David ^a,c   Kiernan, Michael ^a,c  

^a TUFTS MEDICAL CENTER   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bivalirudin; Direct thrombin inhibitor; LVAD; Thrombosis

Indexed keywords

BLOOD VESSELS; DIAGNOSIS; DISEASES; ENZYMES; PLATELETS; POLYSACCHARIDES;

BIVALIRUDIN; CONTINUOUS FLOWS; DIRECT THROMBIN INHIBITOR; HEART FAILURE; LVAD; PLATELET ADHESION; POWER SPIKES; THROMBOSIS;

LEFT VENTRICULAR ASSIST DEVICES;

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; EPTIFIBATIDE; HEPARIN; HIRULOG; LACTATE DEHYDROGENASE; WARFARIN; ANTITHROMBIN; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CREATININE CLEARANCE; DRUG COST; DRUG SUBSTITUTION; HEART FAILURE; HEMOLYSIS; HEPARINIZATION; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE THROMBOSIS; MAINTENANCE DRUG DOSE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE ADHESION; THROMBOPLASTIN TIME; THROMBOSIS; TREATMENT OUTCOME; ADVERSE EFFECTS; CASE REPORT; FEMALE; HEART ASSIST DEVICE; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANTITHROMBINS; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; THROMBOSIS;

EID: 84927693469     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000122     Document Type: Article

References (11)

1. Starling RC, Naka Y, Boyle AJ, et al: Results of the post US Food and Drug Administration-approved study with a continuous flow left ventricular assist device as a bridge to heart transplantation. J Am Coll Cardiol 57:1890-1898, 2011.
2. Slaughter MS, Rogers JG, et al: Advanced heart failure treated with continuous flow left ventricular assist device. New Engl J Med 361:2241-2251, 2009.
3. Miller LW, Pagani FD, Russell SD, et al: Use of a continuous flow device in patients awaiting heart transplantation. New Engl J Med 357:885-896, 2007.
4. Starling RC, Moazami N, Silvestry SC, et al: Unexpected abrupt increase in left ventricular assist device thrombosis. New Engl J Med 370:33-40, 2014.
5. Najjar SS, Slaughter MS, Pagani FD, et al: An analysis of pump thrombosis events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 33:23-34, 2014.
6. Goldstein DJ, John R, Salerno C, et al: Algorithm for the diagnosis and management of suspected pump thrombosis. J Heart Lung Transplant 32:667-670, 2013.
7. Interagency Registry for Mechanically Assisted Circulatory Support. Manual of Operations: Appendix A. Available at: http://www.intermacs.org. Accessed January 31, 2014.
8. Sarsam SH, Civitello AB, Agunanne EE, Delgado RM: Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation. ASAIO J 59: 448-449, 2013.
9. Warkentin TE, Greinacher A, Koster A: Bivalirudin. Thromb Haemost 99: 830-839, 2008.
10. Van De Car DA, Rao SV, Ohman EM. Bivalirudin: A review of the pharmacology and clinical application. Expert Rev Cardiovasc Ther 8: 1673-1681, 2010.
11. Bertrand OF, Jolly SS, Rao SV, et al: Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention. Am J Cardiol 110: 599-606, 2012.